Keyphrases
Solid Tumors
100%
Minimal Residual Disease
100%
Circulating Tumor DNA (ctDNA)
100%
DNA Detection
30%
Bloodstream
20%
Detection Method
20%
Tumor Malignancy
20%
Genetic Variants
10%
Disease Diagnosis
10%
Malignancy
10%
Molecular Targets
10%
Malignant Tumor
10%
Combinatorial Approach
10%
Clinical Practice
10%
Protein Biomarkers
10%
Early Disease
10%
Tumor mutational Burden
10%
Genomic Landscape
10%
Proviral DNA
10%
Clonal Hematopoiesis of Indeterminate Potential
10%
Accurate Method
10%
Disease Resistance
10%
Bodily Fluids
10%
DNA Data
10%
Biopsy Techniques
10%
Tumor Genomics
10%
Methods for Detection
10%
Non-invasive Monitoring
10%
Localized Disease
10%
Release Mechanism
10%
Residual Disease
10%
DNA Analysis
10%
Error Correction
10%
Liquid Biopsy
10%
Cell-free DNA (cfDNA)
10%
Detection Result
10%
Quantification Method
10%
Treatment Personalization
10%
Molecular Barcoding
10%
Circulating Proteins
10%
Imaging Surveillance
10%
Systemic Targeted Therapy
10%
Commercial Platform
10%
Assay Sensitivity
10%
Size Characteristics
10%
Somatic Mosaicism
10%
DNA Quantification
10%
Time Assessment
10%
Immunology and Microbiology
Mosaicism
100%
Hematopoiesis
100%
Liquid
100%
DNA Barcoding
100%
Detection Technique
100%
DNA Virus
100%
Medicine and Dentistry
Solid Malignant Neoplasm
100%
Minimal Residual Disease
100%
Circulating Tumor DNA
100%
Cancer
30%
Neoplasm
20%
Disease
20%
Biological Marker
10%
Malignant Neoplasm
10%
Somatics
10%
Virus DNA
10%
Sensitivity and Specificity
10%
Systemic Therapy
10%
Hematopoiesis
10%
Disease Resistance
10%
Mosaicism
10%
DNA Determination
10%
Biopsy Technique
10%
Liquid Biopsy
10%
Localized Disease
10%
Cell-Free DNA
10%
Detection Technique
10%
DNA Barcoding
10%
Pharmacology, Toxicology and Pharmaceutical Science
Solid Malignant Neoplasm
100%
Minimal Residual Disease
100%
Circulating Tumor DNA
100%
Disease
30%
Neoplasm
20%
Malignant Neoplasm
10%
Biological Marker
10%
Virus DNA
10%
Noninvasive Monitoring
10%
Disease Resistance
10%